FARVOST
LIVE

Serial Number

79232950

Owner

NOVARTIS AG

Filing Date

Mar 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

FARVOST Trademark

Serial Number: 79232950 • Registration: 5583123

FARVOST is a trademark filed by NOVARTIS AG on March 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 16, 2018

Registration Date

October 16, 2018

Published for Opposition

July 31, 2018

Cancellation Date

May 2, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 2, 2026 INTR
CANCELLED SECTION 71
May 2, 2025 C71T
NOTIFICATION PROCESSED BY IB
Jan 4, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 15, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTICE OF PUBLICATION
Jul 11, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 8, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 5, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 29, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 24, 2018 SDRC